Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa b in a rat model of chronic constriction injury

Anesthesia and Analgesia

Volumn 118, Issue 5, 2014, Pages 1090-1096

  Zhou, Chenghua ^a   Shi, Xiaotian ^a,b   Huang, He ^a   Zhu, Yangzi ^a   Wu, Yuqing ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Sixth People's Hospital of Xuzhou City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONTELUKAST; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ACETIC ACID DERIVATIVE; DIAGNOSTIC AGENT; INTERLEUKIN DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PROTEIN KINASE INHIBITOR; QUINOLINE DERIVATIVE;

ADULT; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; DRUG DOSE COMPARISON; EXPERIMENTAL SCIATIC NERVE INJURY; HYPERALGESIA; LATENT PERIOD; MALE; MICROGLIA; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPINAL CORD; ANIMAL; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HEAT; METABOLISM; NEURALGIA; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; STENOSIS, OCCLUSION AND OBSTRUCTION; STIMULATION; WESTERN BLOTTING;

ACETATES; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HOT TEMPERATURE; INTERLEUKINS; LEUKOTRIENE ANTAGONISTS; MALE; MICROGLIA; NEURALGIA; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHYSICAL STIMULATION; PROTEIN KINASE INHIBITORS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902197907     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000174     Document Type: Article

References (36)

1. Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: A practical guide for the clinician. CMAJ 2006;175:265-75.
2. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23-37.
3. Bradesi S. Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol Motil 2010;22:499-511.
4. Nakagawa T, Kaneko S. Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 2010;114:347-53.
5. Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009;10:23-36.
6. Guasti L, Richardson D, Jhaveri M, Eldeeb K, Barrett D, Elphick MR, Alexander SP, Kendall D, Michael GJ, Chapman V. Minocycline treatment inhibits micro glial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain 2009;5:35.
7. Zhang X, Xu Y, Wang J, Zhou Q, Pu S, Jiang W, Du D. The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats. J Neural Transm 2012;119:329-36.
8. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol 2013; 716:106-19.
9. Okubo M, Yamanaka H, Kobayashi K, Noguchi K. Leukotriene synthases and the receptors induced by peripheral nerve injury in the spinal cord contribute to the generation of neuropathic pain. Glia 2010;58:599-610.
10. Okubo M, Yamanaka H, Kobayashi K, Fukuoka T, Dai Y, Noguchi K. Expression of leukotriene receptors in the rat dorsal root ganglion and the effects on pain behaviors. Mol Pain 2010;6:57.
11. Muthuraman A, Ramesh M, Sood S. Ameliorative potential of montelukast on ischemia-reperfusion injury induced vasculitic neuropathic pain in rat. Life Sci 2012;90:755-62.
12. Zhang XY, Wang XR, Xu DM, Yu SY, Shi QJ, Zhang LH, Chen L, Fang SH, Lu YB, Zhang WP, Wei EQ. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation. J Pharmacol Exp Ther 2013;346:328-41.
13. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
14. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
15. Sun T, Song WG, Fu ZJ, Liu ZH, Liu YM, Yao SL. Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br J Anaesth 2006;97:553-8.
16. Costa B, Trovato AE, Colleoni M, Giagnoni G, Zarini E, Croci T. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Pain 2005;116:52-61.
17. Lee HL, Lee KM, Son SJ, Hwang SH, Cho HJ. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 2004;15:2807-11.
18. Kiguchi N, Kobayashi Y, Kishioka S. Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol 2012;12:55-61.
19. Gabay E, Wolf G, Shavit Y, Yirmiya R, Tal M. Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. Eur J Pain 2011;15:242-8.
20. Dominguez E, Rivat C, Pommier B, Mauborgne A, Pohl M. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem 2008;107:50-60.
21. Lee KM, Jeon SM, Cho HJ. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. Eur J Pain 2010;14:682.e1-12.
22. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin- 1beta, interleukin-6, and tumor necrosis factor- Alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008;28:5189-94.
23. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, Wei F, Dubner R, Ren K. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007;27:6006-18.
24. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, Mao J. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 2004;24:8595-605.
25. Kuang X, Huang Y, Gu HF, Zu XY, Zou WY, Song ZB, Guo QL. Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol 2012;676:51-6.
26. Al-Amran FG, Hadi NR, Hashim AM. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats. Eur J Cardiothorac Surg 2013;43:421-7.
27. Sener G, Sakarcan A, Sehirli O, Ekşioglu-Demiralp E, Sener E, Ercan F, Gedik N, Yegen BC. Chronic renal failure-induced multiple- organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins Other Lipid Mediat 2007;83:257-67.
28. Sener G, Sehirli O, Velioʇlu-Oʇünç A, Cetinel S, Gedik N, Caner M, Sakarcan A, Yegen BC. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res 2006;54:65-71.
29. Niederberger E, Geisslinger G. The IKK-NF-kappaB pathway: A source for novel molecular drug targets in pain therapy? FASEB J 2008;22:3432-42.
30. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000;6:441-8.
31. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJ. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 2004;19:3375-81.
32. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL. Cytokine involvement in dynorphin-induced allodynia. Pain 2000;84:159-67.
33. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40.
34. Schäfers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003;23:2517-21.
35. Xu L, Huang Y, Yu X, Yue J, Yang N, Zuo P. The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury. Anesth Analg 2007;105:1838-44.
36. Meotti FC, Posser T, Missau FC, Pizzolatti MG, Leal RB, Santos AR. Involvement of p38MAPK on the antinociceptive action of myricitrin in mice. Biochem Pharmacol 2007;74:924-31.